Important Announcement and Letter from Ipsen Regarding the MOVE Trial and a Pause in Dosing

The IFOPA is sharing this important news release from Ipsen about the MOVE Trial. If you have questions, you should contact your Principal Investigator.

Read the press release.

Read a letter from Ipsen.

Make a Difference

Donate Connect Fundraise

Already a Member? Sign In

Sign Up for FOP Connection, Our Monthly eNewsletter